Organisation
Nuclear Medicine
Current researchers
1 - 10 of 35 results
- Simon Arits (Member)
- Jesse Asiedu (Member)
- Kelly Boumon (Member)
- Sophie Bourgeois (Member)
- Amelientje Bracke (Member)
- Vicky Caveliers (Member)
- Veerle De Grove (Member)
- Lynn De Mey (Member)
- Steffi De Trif (Member)
- Jens Debacker (Member)
Projects
1 - 7 of 7
- Flanders BioImaging: Leading Imaging Application Integrated Service and Enablement (FBI-LIAISE).From1 Jan 2023 → TodayFunding: FWO International research infrastructure (IRI)
- Development of a novel chemoenzymatic technology to generate radiofluorinated PET tracersFrom1 Nov 2021 → TodayFunding: FWO junior postdoctoral fellowship
- SBO project: Nanobody Life Time imaging to Enhance Surgery (NLITESurgery)From1 Oct 2021 → TodayFunding: FWO Strategic Basic Research (SBO)
- H2020: CSA: EURAMED rocc-n-roll: title EURopeAn MEDical application and Radiation prOteCtion Concept: strategic research agenda aNd ROadmap interLinking to heaLth and digitisation aspects (OZR EU BONUS)From1 Sep 2020 → 31 Aug 2023Funding: BOF - mobility
- H2020: CSA: EURAMED rocc-n-roll: title EURopeAn MEDical application and Radiation prOteCtion Concept: strategic research agenda aNd ROadmap interLinking to heaLth and digitisation aspectsFrom1 Sep 2020 → 31 Aug 2023Funding: H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and wellbeing
- GEAR: Integrating a multimodal approach to address current challenges in immunotherapy (INTEGRAL)From1 Jan 2020 → TodayFunding: IOF - technology validation in real environment, IOF - mandates
- Connect 2018: IMMUNE-IMAGE: Specific Imaging of Immune Cell Dynamics Using Novel Tracer StrategiesFrom10 Oct 2018 → 11 Dec 2018Funding: Brussels Capital Region
Publications
1 - 10 of 105
- Open surgery versus primary radiotherapy in T4b sinonasal carcinoma
Authors: Jens Debacker, Wouter Huvenne, Katrien Bonte, Wilfried De Neve, Philippe Deron, Piet Ost, Thibaut Van Zele, Hubert Vermeersch, Fréderic Duprez
Pages: 93-99 - High-Resolution 18F-FDG PET/CT for Assessing Three-Dimensional Intraoperative Margins Status in Malignancies of the Head and Neck, a Proof-of-Concept(2021)
Authors: Jens Debacker, Vanessa Schelfhout, Lieve Brochez, David Creytens, Yves D'Asseler, Philippe Deron, Vincent Keereman, Koen Van de Vijver, Christian Vanhove, Wouter Huvenne
- Size and affinity kinetics of nanobodies influence targeting and penetration of solid tumours(2020)
Authors: Pieterjan Debie, Chrystel Lafont, Michel Defrise, Inge Hansen, Danny M van Willigen, Fijs WB van Leeuwen, Rik Gijsbers, Matthias D'Huyvetter, Nick Devoogdt, Tony Lahoutte, et al.
Pages: 34-42 - Nanobody-coupled microbubbles as novel molecular tracer(2012)
Authors: Sophie Hernot, Sunil Unnikrishnan, Zhongmin Du, Talent Shevchenko, Bernard Cosyns, Alexis Broisat, Jakub Toczek, Vicky Caveliers, Serge Muyldermans, Tony Lahoutte, et al.
Pages: 346-353 - Pseudo-tendinopathy on MRI of the navicular and tarsometatarsal parts of the tibialis posterior tendon(2022)
Authors: Beyza Gungor, Veerle De Grove, Inneke Willekens, Nico Buls, Johan De Mey, Michel De Maeseneer
- A surprising finding during solid-phase gastric emptying scintigraphy(2021)
Authors: Anne-Sophie Hambye, Olga Kosmopoulou
- Salvage total laryngectomy for squamous cell carcinoma of the larynx and hypopharynx: Validated prognostic nomograms predicting oncological outcomes(2024)
Authors: Jeroen Meulemans, Alexander Van Boven, Jens Debacker, Annouschka Laenen, Pierre Delaere, Charlotte Van Lierde, Wouter Huvenne, Vincent Vander Poorten
Pages: 46-56 - Anti-human PD-L1 Nanobody for Immuno-PET Imaging(2020)
Authors: Jessica Bridoux, Katrijn Broos, Quentin Lecocq, Pieterjan Debie, Charlotte Martin, S Ballet, Geert Raes, Sara Neyt, , Karine Breckpot, et al.
Pages: 1-15 - Labeling of Anti-HER2 Nanobodies with Astatine-211: Optimization and the Effect of Different Coupling Reagents on Their in Vivo Behavior(2019)
Authors: Yana Dekempeneer, Tom Back, Emma Aneheim, Holger Jensen, Janik Puttemans, Catarina Xavier, Marleen Keyaerts, Stig Palm, Per Albertsson, Tony Lahoutte, et al.
Pages: 3524-3533 - A Phase 2 Clinical Trial of Trametinib and Low-Dose Dabrafenib in Patients with Advanced Pretreated NRASQ61R/K/L Mutant Melanoma (TraMel-WT)(2021)
Authors: G Awada, Julia Katharina Schwarze, Jens Tijtgat, Giuseppe Fasolino, Hendrik Everaert, Bart Neyns